The trial of the drugs, already approved for malaria, cancer and autoimmune diseases, will involve researchers at more than 600 hospitals in 52 countries.
View original article
Contributor: Emily Anthes
The trial of the drugs, already approved for malaria, cancer and autoimmune diseases, will involve researchers at more than 600 hospitals in 52 countries.
View original article
Contributor: Emily Anthes